The global hospital-acquired infection control market is projected to generate $34,909.7 million revenue by 2030, advancing at a CAGR of 1.6% during 2021–2030. Key factors driving the market include the increasing number of surgical procedures, growing awareness of environmental & personal hygiene, and subsequent growth in the prevalence of chronic diseases.
The COVID-19 pandemic impacted the industry positively. Due to the drastically increased cases of the COVID-19, there was a significant rise in patients’ admission to hospitals. Thus, measures like sterilization and disinfection were in high demand during the pandemic time.
The disnfection category held a larger revenue share, of around 68%, in the market in 2021. This is mainly because, in hospitals and ambulatory care centers, the usage of disinfectants is very high. The COVID-19 pandemic helped the market growth in this category by increasing the demand for disposable, safe, and effective methods to stop the virus from spreading. Moreover, cleaning and disinfection of surfaces in healthcare facilities are becoming increasingly important in a multi-barrier approach for preventing infections, in addition to hand hygiene and proper reprocessing of medical devices.
Geographically, North America is the largest contributor to the market, holding a revenue share of 35% in 2021. This is due to the surging focus on healthy lifestyles and disease prevention among people and the increasing demand and adoption of sterilization and disinfection products and services, in the region. Moreover, the increase in the geriatric population, the rise in the need for HAI control to reduce the prevalence of infections, and the implementation of favorable government initiatives and stringent sterilization and disinfection regulations are driving the regional market.
Whereas, the APAC market is expected to witness the fastest growth during the forecast period. This can be ascribed to the rising number of hospitals, increasing medical tourism, growing aging population, and surging cases of chronic diseases in the region.
Players in the hospital-acquired infection control industry have been involved in acquisitions to remain competitive in the market. For instance, in January 2021, Steris plc acquired Cantel Medical, a global provider of infection prevention products and services primarily to endoscopy and dental customers. With this acquisition, the company will offer a broader set of customers with a more diversified selection of infection prevention and procedural products and services.
Moreover, in November 2020, STERIS plc acquired Key Surgical, a portfolio company of Water Street Healthcare Partners LLC, and a provider of sterile processing, operating room, and endoscopy products. This acquisition increased STERIS' revenue by 35% and expanded the company's range of products.
The major players operating in the hospital-acquired infection control market include STERIS plc, Sotera Health Company, Getinge AB, Advanced Sterilization Products (ASP), Ecolab Inc., 3M Company, MATACHANA GROUP, MMM Group, Belimed AG, Reckitt Benckiser, and Contec Inc.